Maqdasy, S.* ; Lecoutre, S.* ; Renzi, G.* ; Frendo-Cumbo, S.* ; Rizo-Roca, D.* ; Moritz, T.* ; Juvany, M.* ; Hodek, O.* ; Gao, H.* ; Couchet, M.* ; Witting, M. ; Kerr, A.* ; Bergo, M.O.* ; Choudhury, R.P.* ; Aouadi, M.* ; Zierath, J.R.* ; Krook, A.* ; Mejhert, N.* ; Rydén, M.*
Impaired phosphocreatine metabolism in white adipocytes promotes inflammation.
Nat. Metab. 4, 190-202 (2022)
The mechanisms promoting disturbed white adipocyte function in obesity remain largely unclear. Herein, we integrate white adipose tissue (WAT) metabolomic and transcriptomic data from clinical cohorts and find that the WAT phosphocreatine/creatine ratio is increased and creatine kinase-B expression and activity is decreased in the obese state. In human in vitro and murine in vivo models, we demonstrate that decreased phosphocreatine metabolism in white adipocytes alters adenosine monophosphate-activated protein kinase activity via effects on adenosine triphosphate/adenosine diphosphate levels, independently of WAT beigeing. This disturbance promotes a pro-inflammatory profile characterized, in part, by increased chemokine (C-C motif) ligand 2 (CCL2) production. These data suggest that the phosphocreatine/creatine system links cellular energy shuttling with pro-inflammatory responses in human and murine white adipocytes. Our findings provide unexpected perspectives on the mechanisms driving WAT inflammation in obesity and may present avenues to target adipocyte dysfunction.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Activated Protein-kinase; Adipose-tissue; Creatine-kinase; Obesity; Ampk; Expression; Thermogenesis; Transport; Health; Target
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2022
Prepublished im Jahr
HGF-Berichtsjahr
2022
ISSN (print) / ISBN
2522-5812
e-ISSN
2522-5812
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 4,
Heft: 2,
Seiten: 190-202
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Springer
Verlagsort
London
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
30202 - Environmental Health
Forschungsfeld(er)
Enabling and Novel Technologies
Environmental Sciences
PSP-Element(e)
G-505700-001
G-504800-001
Förderungen
Margareta af Uggla's foundation
Swedish Research Council, KI infrastructure and Centre for Innovative Medicine
Novo Nordisk
Fondation Bettencourt Schueller
Societe Francophone du Diabete
Universite Clermont Auvergne
Strategic Research Programme in Diabetes at Karolinska Institutet
Stockholm County Council
Swedish Diabetes Foundation
Knut and Alice Wallenbergs Foundation
NovoNordisk Foundation
ERC-SyG SPHERES
Swedish Research Council
CIMED
Copyright
Erfassungsdatum
2022-05-04